FDA Warns Eastern Pharmacy in Florida Of Deficiencies in Sterile Drug Production

The Food and Drug Administration told Eastern Pharmacy Inc., in Ocala, Fla., that its investigators found significant deficiencies in the company’s production of sterile drugs, according to a warning letter posted Nov. 18 on the FDA’s website.

The FDA said it inspected the pharmacy after receiving notification from the Florida Department of Business and Professional Regulation of serious adverse events in at least 37 patients who had received injections of Avastin (bevacizumab) or Lucentis (ranibizumab) repackaged by Eastern Pharmacy. Both products treat eye diseases and are made by Basel, Switzerland-based Roche Holding AG.

The agency said that during an inspection ...